Discovery of MBL-AB01: a novel antibacterial xanthone antibiotic with high activity against methicillin-resistant Staphylococcus aureus
Applied and Environmental Microbiology · 2026
DOI: 10.1128/aem.01346-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied and Environmental Microbiology, 2026. Verfasst von Kristin Fløgstad Degnes und 14 weiteren Autor:innen. Beteiligte Einrichtung: SINTEF Industry, Biotechnology and Nanomedicine, Trondheim, Norway. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Xanthones, Actinobacteria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges Forskningsråd, MarBiLeads/Norges Forskningsråd, HORIZON EUROPE European Innovation Council.
Abstract (Originalsprache)
A novel compound denoted MBL-AB01 was isolated from a marine Actinoalloteichus , which belongs to a rare and underexplored class of Actinobacteria . This work demonstrates that the novel compound MBL-AB01 shows very high activity in vitro against six methicillin-resistant Staphylococcus aureus strains, and high activity against a panel of three other Gram-positive strains, including a vancomycin-resistant Enterococcus faecium . Structure elucidation of the compound revealed that MBL-AB01 is a polycyclic xanthone antibiotic closely related to the bioactive compounds: xantholipin and lysolipin. This class of antibiotics has caught interest due to its unique chemical structure and diverse biological activity. The gene cluster encoding MBL-AB01 production was identified, and the individual genes within the cluster were annotated along with proposed functional roles. The compound was produced by bioreactor fermentations, and significantly higher yields of MBL-AB01 were obtained after classical mutagenesis and fermentation process improvements. IMPORTANCE Methicillin-resistant Staphylococcus aureus (MRSA) infections have become a great challenge in hospitals over the last decades, and MRSA is currently one of the six pathogens on the World Health Organization priority list. Here, we demonstrate that the novel antibiotic MBL-AB01 has excellent antibacterial properties against six S. aureus strains, including MRSA. MBL-AB01 belongs to the poorly explored class of polycyclic xanthones, thereby fulfilling innovation criteria for the development of new antibiotics. The compound can be produced in sufficient amounts for early formulation development and pre-clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SINTEF Industry, Biotechnology and Nanomedicine, Trondheim, Norway.
- Department of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology, Trondheim, Norway.
- RG Discovery AB, Lund, Sweden.
ORCID-Profile: Kristin Fløgstad Degnes, Anna Nordborg, Giang-Son Nguyen, Guro Kruge Nærdal, Tonje Marita Bjerkan Heggeset, Peter Molesworth, Sigrid Hakvåg, Vu To Nakstad, Johan Evenäs, Klara Jonasson, Alexander Wentzel, Geir Klinkenberg, Håvard Sletta
Förderung
- Norges Forskningsråd
- MarBiLeads/Norges Forskningsråd
- HORIZON EUROPE European Innovation Council
Zitieren
APA
Degnes, K. F., Nordborg, A., Nguyen, G. S., Nærdal, G. K., Heggeset, T. M. B., Molesworth, P., Hakvåg, S., Aune, R., Nakstad, V. T., Evenäs, J., Jonasson, K., Ellingsen, T. E., Wentzel, A., Klinkenberg, G., & Sletta, H. (2026). Discovery of MBL-AB01: a novel antibacterial xanthone antibiotic with high activity against methicillin-resistant Staphylococcus aureus. Applied and Environmental Microbiology. https://doi.org/10.1128/aem.01346-25
Vancouver
Degnes KF, Nordborg A, Nguyen GS, Nærdal GK, Heggeset TMB, Molesworth P, et al. Discovery of MBL-AB01: a novel antibacterial xanthone antibiotic with high activity against methicillin-resistant Staphylococcus aureus. Applied and Environmental Microbiology. 2026. doi:10.1128/aem.01346-25
BibTeX
@article{Degnes2026,
author = {Degnes, Kristin Fløgstad and Nordborg, Anna and Nguyen, Giang-Son and Nærdal, Guro Kruge and Heggeset, Tonje Marita Bjerkan and Molesworth, Peter and Hakvåg, Sigrid and Aune, Randi and Nakstad, Vu To and Evenäs, Johan and Jonasson, Klara and Ellingsen, Trond Erling and Wentzel, Alexander and Klinkenberg, Geir and Sletta, Håvard},
title = {Discovery of MBL-AB01: a novel antibacterial xanthone antibiotic with high activity against methicillin-resistant Staphylococcus aureus},
journal = {Applied and Environmental Microbiology},
year = {2026},
doi = {10.1128/aem.01346-25}
}
EUVIMED